Literature DB >> 7446125

Epidemiology of Pseudomonas aeruginosa infection in patients treated at a cystic fibrosis centre.

N Høiby, K Rosendal.   

Abstract

484 isolates of P. aeruginosa were obtained from the respiratory tract of 45 out of 70 cystic fibrosis (CF) patients of monthly examinations during one year at the Danish CF Centre. All isolates were serogrouped (O-antigens) and phage typed, and in this way 99 per cent of the isolates could be grouped and/or typed. The isolates from CF patients belonged to many different sero-groups, but 55 per cent were polyagglutinable, and most of these belonged to the 0-3/9 complex. This was significantly different from the distribution into O-groups of isolates obtained from non-CF patients. The results of the combined phage typing and sero-grouping of the isolates revealed the occurrence of 13 clusters of distinct epidemiological types of P. aeruginosa among small groups (2-10 individuals) of CF patients. The predominating endemic strain, which was isolated from 10 (22 per cent) of the patients, belonged to the 0-3/9 complex and was lysed by phage 109, either alone or in combination with a few other phages. Furthermore, in a few cases the eradication of another strain of P. aeruginosa by chemotherapy was followed by colonization of the lungs with the above-mentioned predominating strain, and this strain was associated with high lethality. According to these results, measures should be undertaken to identify and eliminate routes of cross-infection in CF centres in order to diminishe the prevalence of P. aeruginosa infection and thereby reduce the lethality of CF patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7446125     DOI: 10.1111/j.1699-0463.1980.tb02617.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand B        ISSN: 0105-0656


  22 in total

1.  Evaluation of random amplified polymorphic DNA typing of Pseudomonas aeruginosa.

Authors:  M Campbell; E Mahenthiralingam; D P Speert
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

2.  Heterogeneity, persistence, and distribution of Pseudomonas aeruginosa genotypes in cystic fibrosis patients.

Authors:  M Fegan; P Francis; A C Hayward; J A Fuerst
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

3.  In vitro and in vivo generation and characterization of Pseudomonas aeruginosa biofilm-dispersed cells via c-di-GMP manipulation.

Authors:  Song Lin Chua; Louise D Hultqvist; Mingjun Yuan; Morten Rybtke; Thomas E Nielsen; Michael Givskov; Tim Tolker-Nielsen; Liang Yang
Journal:  Nat Protoc       Date:  2015-07-09       Impact factor: 13.491

4.  Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis.

Authors:  D P Speert; S W Farmer; M E Campbell; J M Musser; R K Selander; S Kuo
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

5.  Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis.

Authors:  E Mahenthiralingam; M E Campbell; J Foster; J S Lam; D P Speert
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

6.  Use of a pilin gene probe to study molecular epidemiology of Pseudomonas aeruginosa.

Authors:  D P Speert; M E Campbell; S W Farmer; K Volpel; A M Joffe; W Paranchych
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

7.  Effect of oral immunization with Pseudomonas aeruginosa on the development of specific antibacterial immunity in the lungs.

Authors:  J Freihorst; J M Merrick; P L Ogra
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

8.  Interaction of gentamicin with the A band and B band lipopolysaccharides of Pseudomonas aeruginosa and its possible lethal effect.

Authors:  J L Kadurugamuwa; J S Lam; T J Beveridge
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

9.  Risk of cross-colonization and infection by Pseudomonas aeruginosa in a holiday camp for cystic fibrosis patients.

Authors:  J A Hoogkamp-Korstanje; J F Meis; J Kissing; J van der Laag; W J Melchers
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

10.  Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis.

Authors:  E Mahenthiralingam; M E Campbell; D P Speert
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.